Familial cancer associated with a polymorphism in ARLTS1 - Wikidata - wikimedia - TriplyDB

Familial cancer associated with a polymorphism in ARLTS1

Familial cancer associated with a polymorphism in ARLTS1

http://www.wikidata.org/entity/Q28246251

about

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis MicroRNA signatures in human cancers miR-15a and miR-16-1 in cancer: discovery, function and future perspectives Characterization of microRNA expression profiles in normal human tissues Long-term vector integration site analysis following retroviral mediated gene transfer to hematopoietic stem cells for the treatment of HIV infection.ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.Multi-tissue microarray analysis identifies a molecular signature of regeneration.ARLTS1 and prostate cancer risk--analysis of expression and regulation.Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma Genomic approaches to chronic lymphocytic leukemia.Regulatory mechanisms of microRNAs involvement in cancer.MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.Susceptibility genes and B-chronic lymphocytic leukaemia.Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology.Inherited predisposition to chronic lymphocytic leukemia ARLTS1 polymorphisms and basal cell carcinoma of the skin.Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology.The potential of miRNAs as biomarkers for multiple myeloma.Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.Involvement of ARLTS1 in chemotherapy and apoptosis in ovarian cancer cell line.Prediction of cancer outcome using DNA microarray technology: past, present and future.The molecular basis of familial chronic lymphocytic leukemia.MicroRNAs and cancer.ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling.MAPping the kinase landscape of macrophage activation.

P2860

Q24604540-FC31D68D-2E71-4E5E-A446-30F8AE940403 Q24685598-186B7531-DBC1-4DE4-8CCB-8725425FFEAA Q27860962-EB895D7A-8EF0-4DC4-88BE-B77410AFF79F Q28247489-F7C1661D-C22A-4991-9C3D-2841AEC62E59 Q29615492-DCA167B8-01E6-4364-B5D1-F8021E2B504B Q33400359-136F05A3-5B2F-425D-8290-67304BACED4B Q33795684-D92D80E1-9938-4EF6-ADF4-21F637A86257 Q34058710-C30E87B7-3A1F-4FF7-A78D-31A78CDCE15B Q34150434-8AD265C9-1612-403A-836D-4FC3EB321211 Q34540644-5C69A32C-32FE-4E00-9C4C-852920263DCC Q34938287-F0615D5B-65BE-4CC6-8A14-6B673689FE09 Q35100928-AB7B6661-AFA2-486E-858B-F9AD8B835EAA Q36113106-394A7CBF-B906-441B-809D-21B8CF639545 Q36287377-DD618643-2303-4BFA-A254-FD1372A16703 Q36671959-D0EE5EB8-AF06-414D-9762-6C265A170DAC Q36737322-B1F4BBC3-7282-4E3D-980D-1E3EE2487867 Q36897389-23866E99-6373-47B9-96BF-F0BA7A5919C0 Q37004865-5E01630B-EBD8-45EC-A0FE-1E9299DFC58D Q37004883-A1FF4C89-8223-4C0B-AB32-58FBA79AC12D Q37312999-7BC88D1F-B870-42D6-A50F-AD58AC477FA2 Q37319074-D93136A0-6273-4D7D-A892-2ADE131EFDAA Q37330232-82D1F253-0BD6-45D0-A789-C4F3A44BE12B Q37450534-61C07641-6B38-416D-8BF7-906033AA1F3B Q38152226-8468AF04-01EA-4678-8078-23EFE69D5213 Q38237446-5060E65F-59FA-45D3-8087-7A4E9CFF1EB6 Q39004167-A86998DF-B205-4907-BC2A-FBD10DC773D3 Q39620608-F00145A4-51A9-4934-B024-63B66FC38D3B Q39998940-7A213328-F859-4B88-AFC2-EA134830B7F6 Q42831544-8A6D3022-B092-4FEA-A8A0-B83763E81FFA Q48324133-FACE7474-EAA5-4C5A-A785-99EF67BED10E Q52331917-A80901F9-619F-46AD-A5E6-3BEDB25B5224 Q55417619-6FB03E1F-0BF9-4C7B-93B9-71550A6B9E40

P2860

Familial cancer associated with a polymorphism in ARLTS1

http://www.wikidata.org/entity/Q28246251

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Familial cancer associated with a polymorphism in ARLTS1

@ast

Familial cancer associated with a polymorphism in ARLTS1

@en

Familial cancer associated with a polymorphism in ARLTS1

@nl

type

label

Familial cancer associated with a polymorphism in ARLTS1

@ast

Familial cancer associated with a polymorphism in ARLTS1

@en

Familial cancer associated with a polymorphism in ARLTS1

@nl

prefLabel

Familial cancer associated with a polymorphism in ARLTS1

@ast

Familial cancer associated with a polymorphism in ARLTS1

@en

Familial cancer associated with a polymorphism in ARLTS1

@nl

P1433

Q28246251-DB2EE9AD-6507-4645-BC3F-E13855801B01

P1476

Q28246251-8E65C914-A409-4AD5-9C53-3F7E5EE29E3B

P2093

Q28246251-13C33367-E081-4BD7-BDFF-6CC9DFEC2DE8

Q28246251-14D2ED8B-1559-4347-8D26-B53527553B41

Q28246251-21A1A622-87DC-48F6-833B-12639B0DE389

Q28246251-2B0F5124-53BA-4243-BF2E-6B8185E6B715

Q28246251-43FB7E6E-725B-48A7-9BD0-939A578C410C

Q28246251-4520B048-5964-4A58-AEA6-D39CA3F1FE2B

Q28246251-4ABAD678-EB66-4D38-84B2-3A68F83DAAA2

Q28246251-62D5B33E-5AC6-4484-A182-7C69F6A91AC8

Q28246251-70AC2928-91F2-4D97-93AE-136EB51C61AC

Q28246251-7FA30B29-1174-407C-A793-F2777EA8A54B

P304

Q28246251-6912B3D5-CBED-442E-A88E-BCCB006CBD43

P31

Q28246251-7483F2A3-A02D-4013-9B79-2E2805FA11CD

P356

Q28246251-B8EC4521-BE67-41B7-ACAB-AA3CDECAD458

P407

Q28246251-A44D40A2-6107-416A-B400-818992A31FF1

P433

Q28246251-452F0670-324E-4C95-9516-6F15654CECEA

P478

Q28246251-D6C9B3E9-A196-45DA-8826-A4560D9AA4E1

P50

Q28246251-1ADCC10B-CB8A-4812-BE79-1B7AD2B01CAA

Q28246251-36203AD7-0FA2-44D3-A432-281733A64F63

Q28246251-3D5A036E-A467-4284-9DF5-6DB15F207FBA

Q28246251-6FE1AEFC-303A-479F-AE43-94E922FD3222

Q28246251-82982E90-EA03-4F7D-83E6-5B8D5EB25855

Q28246251-8811BD92-422C-4C18-9DEA-B36724058371

Q28246251-B36598AD-CA40-4404-8609-1FD46953A7BB

Q28246251-B8EA5AD2-C776-4B08-AAC2-53994A30E599

P577

Q28246251-CF8D3982-E249-45F6-9F67-3C830B733D7F

P698

Q28246251-529B9638-DEAF-49C1-93AE-DE7EC353D7D3

P356

P1433

The New England Journal of Medicine

P1476

Familial cancer associated with a polymorphism in ARLTS1

@en

P2093

Andrew K Godwin

http://www.w3.org/2001/XMLSchema#string

Benjamin Movsas

http://www.w3.org/2001/XMLSchema#string

Calin Dan Dumitru

http://www.w3.org/2001/XMLSchema#string

Chang-Gong Liu

http://www.w3.org/2001/XMLSchema#string

Devjani Chatterjee

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Florencia Bullrich

http://www.w3.org/2001/XMLSchema#string

Francesco Trapasso

http://www.w3.org/2001/XMLSchema#string

George Adrian Calin

http://www.w3.org/2001/XMLSchema#string

Guido Bernardi

http://www.w3.org/2001/XMLSchema#string

P304

1667-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA042280

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Manuela Ferracin

Gustavo Baldassarre

Lise Lotte Hansen

Francesca Romana Mauro

Carlo Maria Croce

P577

2005-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15843669

http://www.w3.org/2001/XMLSchema#string